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Hypersomnia
Yves Dauvilliers, MD, PhD;Alain Buguet, MD, PhD
he obvious main symptom of hypersomnia is a
constant complaint of excessive daytime sleep or sleepi-
ness,which affects the everyday life of the patient.In our
mechanized societies,it may impair work performance
and even be involved in accidents at work or while dri-
ving. Although hypersomnia syndromes have been
described for more than a century, starting with nar-
colepsy,
1 it is only in the last 30 years that modern sleep
medicine has stressed the health and economic impacts
of falling asleep at any time. Hypersomnia syndromes
affect a growing proportion of the 15% to 30% of peo-
ple suffering from sleep problems.Hypersomnia is pre-
sent in 4% to 6% of the general population,
2 with a
higher prevalence in men because of sleep apnea syn-
dromes,the main purveyor of excessive daytime sleepi-
ness.
3 In recent years,sleep medicine has benefited from
the impact of hypersomnia and is now in full develop-
ment in industrialized countries.
Although lack of nocturnal sleep is evidently the first eti-
ology to be suspected, excessive sleepiness may result
from a number of different causes,imposing an arbitrary
classification.The approach we propose in this review is
to describe hypersomnia syndromes under several head-
ings.First,we shall discuss the methodological tools avail-
able to explore sleep and wakefulness and then we will
examine the clinical classification of hypersomnia syn-
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Hypersomnia, a complaint of excessive daytime sleep or
sleepiness, affects 4% to 6% of the population, with an
impact on the everyday life of the patient. Methodological
tools to explore sleep and wakefulness (interview, ques-
tionnaires, sleep diary, polysomnography, Multiple Sleep
Latency Test, Maintenance of Wakefulness Test) and psy-
chomotor tests (for example, psychomotor vigilance task
and Oxford Sleep Resistance or Osler Test) help distinguish
between the causes of hypersomnia. In this article, the
causes of hypersomnia are detailed following the con-
ventional classification of hypersomnic syndromes: nar-
colepsy, idiopathic hypersomnia, recurrent hypersomnia,
insufficient sleep syndrome, medication- and toxin-depen-
dent sleepiness, hypersomnia associated with psychiatric
disorders, hypersomnia associated with neurological dis-
orders, posttraumatic hypersomnia, infection (with a spe-
cial emphasis on the differences between bacterial and
viral diseases compared with parasitic diseases, such as
sleeping sickness) and hypersomnia, hypersomnia associ-
ated with metabolic or endocrine diseases, breathing-
related sleep disorders and sleep apnea syndromes, and
periodic limb movements in sleep.  




and toxin-dependent sleepiness,hypersomnia associated
with psychiatric disorders,hypersomnia associated with
neurological disorders,posttraumatic hypersomnia,infec-
tion and hypersomnia, hypersomnia associated with
metabolic or endocrine diseases,breathing-related sleep
disorders and sleep apnea syndromes,and periodic limb
movements in sleep.
Methodological and diagnostic tools
The physician’s first step is to thoroughly interview the
patient and his or her partner to determine the patient’s
sleep habits and hygiene.If hypersomnia is suspected,the
number and duration of diurnal sleep or sleepiness
episodes should be specified.The patient should be asked
whether daytime sleep bouts are refreshing and recu-
perative.A report on sleep quality of the preceding night
should also be obtained.
A sleep diary made up of monthly forms gives an estimate
of the number,duration,and chronology of daily episodes
of sleep and sleepiness.On the monthly form,days are rep-
resented on the vertical axis and hours horizontally.Areas
corresponding to the intersection can be filled in to rep-
resent sleep or somnolence,or even yawning.Eating times
can also be indicated.The diary is completed by subjective
sleep quality questionnaires, such as the Stanford
Sleepiness Scale
4 and the Epworth Sleepiness Scale.
5 For
example,an Epworth score >10 indicates a complaint of
hypersomnia.
Objective measures of daytime somnolence involve
polysomnographic techniques (recording of electroen-
cephalogram [EEG], electro-oculogram [EOG], elec-
tromyogram [EMG], electrocardiogram [ECG], leg
movements,and/or respiratory parameters) during both
nocturnal sleep and the daytime. Polysomnography
allows the distinction between wakefulness, rapid eye
movement (REM) sleep and non-REM sleep (stages 1
to 4,stages 3 and 4 constituting slow-wave sleep [SWS]).
6
Daytime measures of sleepiness use the Multiple Sleep
Latency Test (MSLT).
7The patient lies down in the dark
for five 20-min sessions spaced 2 h apart.For example,in
the case of a patient with nocturnal sleep between 11 PM
and 7 AM, MSLT sessions should occur at 9 AM, 11 AM,
1 PM,3  PM,and 5 PM.The variables of interest are sleep
latency and REM sleep latency (or REM latency).Sleep
latency less than 8 min indicates excessive daytime sleepi-
ness.
8 The patient is considered normal if sleep occurs
after 10 min.Between these two values,the interpreta-
tion should take into account the clinical status of the
patient. REM latencies less than 15 min may also be
pathological,indicating the presence of sleep-onset REM
periods (SOREMP). The presence of at least two
SOREMP on the MSLT,although not highly specific and
sensitive,is generally considered as abnormal and indica-
tive of narcolepsy as the cause of hypersomnia.
A variant of the MSLT is the Maintenance of
Wakefulness Test (MWT).
9The patient is not lying down,
but is seated comfortably in bed,with low lighting placed
behind.During two daytime 20-min sessions,the patient
is asked to look ahead and stay awake as long as possi-
ble.The test ends either after 15 s of microsleep,or after
the occurrence of the first sleep stage,or at the end of the
session if no sleep occurs.The normal limit is 11 min.
Continuous polysomnography can also be performed for
24 h or more to assess the degree of sleepiness.This also
serves to evaluate circadian variations in sleepiness.
Psychomotor tests are used by physicians to evaluate
eventual performance decrements due to excessive day-
time sleepiness.
9 Most tests are based on reaction time,
and may be simple tests in which the patient has to
respond to identical stimuli as fast and efficiently as pos-
sible,or choice reaction time tests,which use stimuli with
clear and specific differences. Among simple reaction
time tests, the psychomotor vigilance task, which lasts
only 10 min,has proven highly sensitive to performance
decrement in hypersomnia.The Oxford Sleep Resistance
Test is an indirect measure of sleep occurrence. The
patient sits in darkness and presses on a button when a
diode lights up (1 s every 3 s).The patient is considered
to have fallen asleep when he or she has missed seven
light cycles.
Many other tests have been proposed,but our purpose is
not to be exhaustive in this review.The application of
such tools and tests helps evaluate fatigue,somnolence,
and vigilance and diagnose hypersomnia syndromes and
distinguish between them.
Narcolepsy
Narcolepsy is a rare, chronic neurological disorder
(0.026% of the general population) caused by the inabil-
ity to regulate sleep-wake cycles normally.It is charac-
terized by excessive diurnal sleepiness and cataplexy.
10At
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experiences fleeting urges to sleep that are often over-
whelming.Individuals fall asleep for a few seconds to sev-
eral minutes.The essential characteristic of such sleep
episodes is that they are short and refreshing,and are fol-
lowed by a normal wakeful state.Cataplexy is a sudden
loss of voluntary muscular tone,without any alteration
of consciousness,in relation to strong emotive reactions
(laughter,noise,fright,etc).In addition to these symp-
toms, either at sleep onset or upon awakening, the
patients may suffer from vivid hallucinations and brief
episodes of sleep paralysis,and report poor sleep quality.
Narcolepsy generally begins in adolescence,but the age
of the first occurrence varies enormously.The cause of
narcolepsy remains unknown,but probably involves an
interaction between genetic and environmental factors,
which trigger the alteration of the hypocretin system
leading to sleep disturbances.Narcolepsy is highly related
to HLA subtypes.
11The familial form of narcolepsy cat-
aplexy is only observed in 10% of cases.
The diagnosis of narcolepsy is essentially clinical,but also
involves a nocturnal polysomnographic recording followed
by an MSLT,during which sleep latency should be below
8 min with at least two SOREMPs.The diagnosis is rein-
forced by the finding of a serological DR2-DQ1 HLA typ-
ing (more precisely DRB1*1501-DQB1*0602).Such an
oligonucleotidic typing is found in 92% of Caucasian nar-
coleptics,compared with only 20% in the general popula-
tion. More recently, narcolepsy has been related to
impaired function of hypocretin-secreting neurones
located in the laterodorsal hypothalamus. In the cere-
brospinal fluid (CSF) of patients,hypocretin-1 concentra-
tion drops
12 and the postmortem pathological examination
of the brain reveals the disappearance of hypocretinergic
neurons.
13,14 An autoimmune origin is one hypothesis.
However,like in the canine narcolepsy model developed
at Stanford, in which a mutation of the gene coding the
receptor 2 of hypocretin is present,
15 a mutation of the
gene coding for preprohypocretin has been reported in
one atypical and severe case of human narcolepsy.
13
Narcolepsy without cataplexy has been described as a
phenotypic variant.The clinical diagnostic criteria are
similar to that of narcolepsy with cataplexy,except that
the cataplexy is not present. However, the association
with the HLA DQB1*0602 is weaker and the decrease
in CSF hypocretin is less frequently encountered.A com-
mon pathophysiology is still a matter of debate.
There is no cure for narcolepsy. None of the currently
available medications enables patients to maintain a per-
manent normal state of alertness.However,the most dis-
abling symptoms,excessive daytime sleepiness and cata-
plexy,can be controlled in most patients.In more recent
years, amphetamine derivatives have frequently been
replaced by modafinil for the treatment of excessive day-
time sleepiness.
16 In cases of persistent excessive daytime
sleepiness,methylphenidate,amphetamine,and mazin-
dol (a derivate of amphetamine) may be of value.
The control of cataplexy is still obtained with antide-
pressants:tricyclics (including imipramine,desipramine,
clomipramine,and protriptyline) and also selective sero-
tonin reuptake inhibitors (including fluoxetine and ser-
traline) and serotonin and noradrenaline reuptake
inhibitors (venlafaxine), which do not have the side
effects of tricyclics. If the symptoms persist, mazindol
may be used since it is active on both diurnal sleepiness
and cataplexy.
17 Gamma-hydroxybutyrate or sodium oxy-
bate in its most recent form represents an alternative
treatment for hypersomnia,cataplexy,and poor sleep at
night.
18 In patients at sickness onset, the intravenous
administration of immunoglobulins, at a high dose of 
1 g/kg/day for 2 days, repeated three times at 
4-week intervals, has been shown to decrease the fre-
quency and severity of cataplexy for several months.
19
The authors suggest that such a treatment may change
the course of the sickness at a time when the autoim-
mune process targeting the cataplexy networks can still
be reversed.
Common-sense behavior counseling may prove to be use-
ful as a complement to pharmacotherapy.Maintenance of
regular sleep schedules to enhance nighttime sleep qual-
ity and short daytime naps are indicated. Patients are
advised to avoid drinking alcohol and caffeine-containing
beverages before bedtime.The treatment regimen can be
modified as symptoms change.Symptoms may get worse,
especially over the two to three decades following their
first occurrence,but they may improve in older patients.
Idiopathic hypersomnia
Idiopathic hypersomnia is a rare condition and is 10
times less frequent than narcolepsy,although no preva-
lence study has ever been conducted.
20 For a long time,it
was confused with narcolepsy,but it was clearly individ-
ualized through polysomnographic studies.
21,22 The
International Classification of Sleep Disorders (ICSD)
8
defines idiopathic hypersomnia as a normal or prolonged
nocturnal sleep episode that is associated with excessiveClinical research
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daytime sleepiness consisting of prolonged (1- to 2-h)
sleep episodes of non-REM sleep.Roth et al
21 described
two clinical forms: a monosymptomatic excessive day-
time sleepiness and a polysymptomatic excessive daytime
sleepiness associated with abnormally long nocturnal
sleep and “sleep drunkenness”upon awakening.These
forms are now described as idiopathic hypersomnia with-
out a long sleep time and idiopathic hypersomnia with a
long sleep time, respectively. Contrary to narcolepsy,
diurnal sleep bouts are not irrepressible and do not
restore normal vigilance, and nocturnal sleep remains
undisturbed,except for a delayed morning awakening.
The condition often starts before 30 years of age.Familial
occurrences are frequent.It is a life-long disorder that
has severe social and professional impact.
23
The diagnosis of idiopathic hypersomnia is often overes-
timated and requires a thorough examination.It is appro-
priate in patients with excessive daytime sleepiness and/or
sleep drunkenness,without any narcolepsy,periodic limb
movements, or sleep apnea syndrome. Nocturnal
polysomnography,to eliminate the latter conditions,is fol-
lowed by MSLT sessions,which reveal short sleep laten-
cies below 8 to 10 min, with less than two SOREMPs.
However,the MSLT procedure requires that the patient
be woken up early.To obtain evidence of abnormally long
sleeping hours,24-h to 48-h polysomnographic recordings
may be necessary.They will reveal that the patient sleeps
for more than 12 h per 24 h,with both long nocturnal sleep
and long daytime naps.
20 If numerous microarousals are
detected,the upper airway resistance syndrome should be
considered.A new sleep recording with esophageal pres-
sure measures will be made to evaluate transpleural pres-
sure.Personality tests are undertaken to exclude psychi-
atric hypersomnia, and cerebral imaging may be
performed according to the clinical context.
As no animal model of idiopathic hypersomnia is avail-
able, pathophysiology of the sickness is speculative.
Treatment of idiopathic hypersomnia uses a number of
stimulant drugs,such as modafinil,which is often effec-
tive on excessive daytime sleepiness.However,sleep iner-
tia persists in most cases.
Recurrent hypersomnia
Recurrent hypersomnia is characterized by episodes of
excessive sleep lasting from a few days to several weeks.
Patients may sleep for at least 18 h a day,and rise only to
eat and void. The episodes are typically separated by
weeks or months,during which normal sleep patterns are
resumed. Excessive sleep may accompany behavior
abnormalities,such as overeating,sexual disinhibition,
and other mental disturbances. This polysymptomatic
form is represented by the Kleine-Levin syndrome 
which occurs in adolescent boys bearing the HLA
DQB1*0201* type.
24 The syndrome may also be idio-
pathic in relation to menstruation.
25 It may even be sec-
ondary to neurological or psychiatric conditions, or a
viral infection that occurred weeks before.The diagnosis
of Kleine-Levin syndrome is mainly clinical.Differential
diagnosis must distinguish recurrent hypersomnia from
obstructive sleep apnea syndrome,narcolepsy,or periodic
limb movement disorder.In order to confirm hypersom-
nia and exclude epilepsy and organic pathology, EEG
and polysomnographic recordings,and cerebral imaging
may prove useful.The etiology of idiopathic recurrent
hypersomnia remains elusive,though most symptoms can
be regarded as a hypothalamic dysfunction.
Recurrent hypersomnia results in major disturbances in
social and family life,and its prognosis is unknown.The
evolution throughout life is favorable in most cases,with
a progressive disappearance of symptoms.Treatment of
recurrent hypersomnia episodes includes stimulants,
despite their frequent lack of efficacy.Prophylactic mea-
sures may be successful,such as prevention with valproate,
carbamazepine,or lithium carbonate,
26 or estroprogesta-




The insufficient sleep syndrome is a disorder that occurs
in an individual who fails to obtain sufficient nocturnal
sleep to support normally alert wakefulness.
8The indi-
vidual is in fact chronically sleep-deprived at his own will,
without being aware of it.Such a situation is increasing
in our modern technologically inclined societies.The indi-
vidual is pressured by socioprofessional imperatives and
feels that he or she does not have the time to do every-
thing.The worker may also be doing shift work.As the
nights pass by,sleep debt increases.
The insufficient sleep syndrome causes 5% to 10% of
consultations for excessive daytime sleepiness.
27The sub-
ject is generally an active or overactive 40-year-old man,
with responsibilities and a high social status.The syn-
drome can also be related to shift work or frequent trans-
meridian airplane trips.Hypersomnia - Dauvilliers and Buguet Dialogues in Clinical Neuroscience - Vol 7 . No.4 . 2005
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As the sleep debt develops,the individual starts suffering
from excessive somnolence in the afternoon,in the evening,
or after meals. Patients report that they sleep 5 to 6 h
nightly on weekdays,and 9 h during the weekends.They
have difficulty rising in the morning and sometimes expe-
rience sleep drunkenness–like episodes.Work and cogni-
tive performance, as well as decision-making, may be
impaired.The patient may also complain of increasing lev-
els of subjective fatigue,mood deterioration,muscular pain,
gastrointestinal upset,and visual disturbances.Symptoms
disappear on weekends and during the holidays.
The diagnosis is mainly performed during interview.
However,in cases of a suspected associated pathology,
such as respiratory disturbances during sleep, a
polysomnographic recording may be indicated. In the
case of insufficient sleep syndrome, this recording will
show a good sleep efficiency (>90%) and short sleep
latency,indicative of a sleep rebound.
Medication- and toxin-dependent sleepiness
Numerous medications are potentially responsible for
excessive daytime sleepiness,such as hypnotic,anxiolytic,
antidepressant,neuroleptic,antihistaminic,antiepileptic
(except for lamotrigine), and antiparkinsonian drugs.
Alcohol presents sedative or stimulant effects, which
depend on dosage and individual susceptibility.
28Acute
alcohol consumption may delay or,in contrast,advance
sleep induction.REM sleep is postponed to the second
half of the night and SWS increases in the first half.
Discontinuation of alcohol consumption is often reported
to be followed by an REM sleep rebound.Chronic alco-
holics sleep poorly, with a reduced amount of REM
sleep,sleep being composed almost exclusively of non-
REM sleep.Acute withdrawal is accompanied by more
frequent REM sleep episodes determining a shortening
of REM–non-REM sleep cycles with decreased SWS.
Hallucinations occurring in this condition have been
hypothesized to be related to REM sleep fragmentation
and/or rebound.In chronic alcoholics who become sober,
shortened REM latency,elevated REM percentages,and
high REM density,
29 as well as lowered SWS percent-
ages,
30 have been reported as predictors of relapse.
Interview should eliminate such drug–sleep interactions.
In the case of drug-induced hypersomnia, careful and
progressive withdrawal and/or substitution must be
undertaken.Treatment withdrawal from stimulants could
in fact be expected to lead to a rebound of sleep,as is the
well-known case in sleep deprivation.
31 Such a rebound
is not observed.For example,amphetamine withdrawal
after its administration during a 64-h sleep deprivation
leads to an alleviated recovery sleep for at least two
nights.
32Tobacco consumption withdrawal in a heavy cig-
arette smoker was reported to provoke excessive day-
time sleepiness with an impairment of work perfor-
mance,which was successfully treated with modafinil.
33
Hypersomnia associated with 
psychiatric disorders
In contrast to insomnia,excessive daytime sleepiness is
rarely associated with psychiatric disorders such as major
depression or major mood disorders.
34 However,no spe-
cific sleep disturbance can be evidenced and no sub-
stance can be blamed for it.In addition,MSLT is mostly
normal;therefore,the diagnosis of hypersomnia in these
conditions is still subject to controversy with a more
probable diagnosis of fatigue.In the northern countries
of the northern hemisphere,seasonal affective disorders
associate hypersomnia with anxiety,irritability,sadness,
sugar bulimia,and increase in body weight.
35
Hypersomnia associated with 
neurological disorders
A number of neurological affections may be accompanied
by excessive daytime sleepiness.Brain tumors
36 or stroke
37
that provoke lesions or a dysfunction of the thalamus,hypo-
thalamus,and brain stem can cause hypersomnia.For exam-
ple,cases of symptomatic narcolepsy have been described
as being associated with such lesions.Neurodegenerative
conditions, Alzheimer’s disease, Parkinson’s disease, or 
multisystem atrophies will often provoke hypersomnia.
36 In
such associations,the main causes of hypersomnia,such as
sleep apnea syndromes,medications,and periodic leg move-
ments,should be explored.
Neuromuscular diseases may provoke breathing disor-
ders and predispose to abnormal sleepiness. Myotonic
dystrophy is of particular interest,and is often associated
with hypersomnia with SOREMP.
38
Posttraumatic hypersomnia
Abnormal sleepiness may be observed within 6 to 18
months of head trauma.Clinically related to idiopathic
hypersomnia,it may be associated with headaches,mem-ory loss,and lack of concentration.
39 Its course depends
on the location and the extent of the initial lesions.
Infection and hypersomnia
Although the initial description of von Economo’s lethar-
gic encephalitis in patients who suffered from pharyngi-
tis dates back to 1917,
40 the influence of bacterial agents
on sleep was revealed 20 to 30 years ago,when the pyro-
genic and hypnogenic actions of muramyl peptides and
endotoxin (bacterial lipopolysaccharides) were
described.
41,42 The hypnogenic effect was recently
extended to the viral envelope glycoproteins.This action
may be mediated by host immune reactions. Several
cytokines are pyrogenic and somnogenic,such as tumor
necrosis factor-α, interferon-β, and interleukin-1.
However, sleep has rarely been analyzed in infectious
patients,due to the general emergency aspects of diseases
such as meningitis or severe viral infection.Research on
polysomnographic examinations in infectious diseases is
therefore scarce,though animal models of bacterial and
viral infection have been extensively used.In parasitic
diseases, human sleep was studied by our team in the
Gambian form of human African trypanosomiasis,sleep-
ing sickness, which is due to the injection of try-
panosomes by tsetse flies.
In both viral and bacterial infections, the initial host’s
immune reaction and hypersomnia,especially centered
on SWS,develop concomitantly.In some diseases,such
as Whipple’s disease
43 or human immunodeficiency virus
(HIV) infection,autoantibodies are produced in the sec-
ond phase and a dramatic decrease in,or disappearance
of,sleep may occur.
44 On the contrary,despite an exten-
sive immune reaction during the initial hemolymphatic
stage of human African trypanosomiasis,sleep remains
undisturbed.
45 However, in the second meningoen-
cephalitic stage, autoantibodies against nervous struc-
tures are widely produced,and both sleep and wakeful-
ness are impaired due to the penetration of the
trypanosome into the central nervous system. At this
stage of sleeping sickness,a “complex polysomnographic
syndrome”is observed with disappearance of circadian
rhythmicity of the alternation of sleep and wake
episodes,which occur at any moment of the day or night,
and appearance of anomalies in sleep structure,and the
occurrence of SOREMP.
45,46 In any case,sleeping sickness
is not a hypersomnia per se,but rather a major disorder
of sleep structure and its circadian regulation.
Therefore,in bacterial and viral diseases sleep modifica-
tions are coupled with immune reactions.The uncoupling
between the acute phase of the immune reaction in
sleeping sickness and sleep-wake patterns is not yet
understood.
Hypersomnia associated with 
metabolic or endocrine diseases
Rarely,hypersomnia may complicate diabetes,hepatic
encephalopathy, hypothyroidism, and acromegaly.
47
Breathing disorders and periodic leg movements that
often accompany metabolic disorders should be explored
in the genesis of such hypersomnia.
Breathing-related sleep disorder and 
periodic limb movements in sleep and 
sleep apnea syndromes
Sleep apnea syndromes
3 and periodic limb movements in
sleep
48 are the most frequent causes of excessive daytime
sleepiness.
Limb movement disorders
Limb movement disorders related to rest and sleep have
been divided into two syndromes,restless legs syndrome
and periodic limb movements during sleep.The latter are
commonly associated with the former,as well as with var-
ious sleep disorders, such as insomnia, narcolepsy, and
sleep apnea syndrome,and also physiological aging.The
limb movements arouse the patients who is unaware of
his or her highly fragmented sleep.
48 Polysomnography
shows lengthened sleep latency,increased waking after
sleep onset,and numerous sleep stage changes;stage 1 is
elevated,while SWS is low.A chronic sleep-wake disor-
der may develop,causing excessive daytime sleepiness.
Restless legs syndrome is a sensorimotor disorder char-
acterized by an urge or a need to move the limbs. It is
usually associated with uncomfortable or unpleasant sen-
sations in the legs, which worsen in the evening or at
night.
49The symptoms begin at rest when the person is
lying or sitting and are relieved by movement such as
walking or stretching.The condition is present in 5% to
10% of the general population.It has been said to be the
“most common and least diagnosed” sleep disorder.
50
Diagnosis relies essentially on the interview with the
physician.
51 Restless legs may be caused by polyneu-
Clinical research
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neuroleptic exposure, or cramps. Objective measures
include polysomnography,with EMG electrodes placed
at the level of the anterior tibialis muscles on both legs,
and the suggested immobilization test (SIT) to provoke
the restless legs symptoms. In the SIT, the patient is
required not to move for 1 h while measures of leg move-
ment and movement intensity are monitored.In 80% of
patients,polysomnography will show periodic limb move-
ments while awake and sensory discomfort may rise dur-
ing the SIT.
Periodic limb movements in sleep are repetitive move-
ments that primarily involve the legs,especially during
non-REM sleep.When patients report sleep-wake com-
plaints,they are said to suffer from periodic limb move-
ment disorder.Movements are counted if they last 0.5 to
5 s and occur in a series of four or more at intervals of 5
to 90 s.The EMG amplitude of the nocturnal limb move-
ments must be 25% or more of the baseline EMG ampli-
tude while awake.The severity of the condition is deter-
mined by the periodic limb movement index (number of
periodic movements per hour of sleep).The periodic limb
movement arousal index is the number of periodic limb
movements associated with EEG arousals per hour of
sleep. Periodic limb movement disorder is defined as
mild (5 to 25 periodic limb movements occur per hour of
sleep),moderate (25 to 50 movements per hour of sleep),
or severe (more than 50 periodic limb movements per
hour of sleep or more than 25 associated with arousals
per hour of sleep).
The pathophysiology of periodic movements has been
related to iron deficiency, which itself is related to
dopaminergic dysfunction, which has led to the recent
publication of dopaminergic-centered therapeutic stan-
dards,
52 dopamine agonists giving positive results.With
the exception of anticholinergics,Parkinsonian medica-
tions benefit the condition.
Sleep apnea-hypopnea syndromes and the upper airway
resistance syndrome
Two clinical entities constitute the essential part of
breathing disorders during sleep:sleep apnea-hypopnea
syndromes and the upper airway resistance syndrome.
53
Obstructive sleep apnea affects up to 4% of middle-aged
male adults, but may also affect women.The generally
obese heavily snoring male patient stops or reduces (by
more than 50%) breathing between 10 s to 1 min.Efforts
to breathe arouse the patient, leading to an extremely
fragmented sleep and excessive daytime sleepiness.The
latter varies to a large extent,from simply falling asleep
in nonstimulating situations to a major symptom with
mental performance decrements,which can be responsi-
ble for car or work accidents.Headaches and fatigue in
the morning, nocturnal polyuria and sexual problems
(from reduced libido to impotence) are commonly
encountered.Hypertension,angina pectoris,cardiores-
piratory failure,and stroke may develop as the disorder
progresses.
The diagnosis is confirmed by polysomnography with the
recording of respiratory parameters. Oronasal sensors
made up of thermocouples or thermistors detect the pas-
sage of airflow by measuring temperature variations at the
nose and mouth openings.However,they may be uncom-
fortable,and so unobtrusive nasal cannulae with separated
left- and right-sided tubings connected to two pressure
transducers have recently been developed.The efficacy of
the measurement of nasal and oral airflow is limited in case
of hypopnea and upper airway resistance.Thoracic and
abdominal straps, made of mercury strain gauges or
graphite rubber,indicate the presence or absence of cen-
tral respiratory drive.Pathological indices are set at five
apneas per hour in the adult (10 per hour in the aged).
These measures allow the distinction between obstructive
(respiratory effort) and central (no respiratory effort) sleep
apnea syndromes. Respiratory effort is measured by
recording pleural pressure through esophageal pressure.
Inspiratory effort is also quantified by pulse transit time,
the time taken for the arterial pulse pressure wave to travel
from the aortic valve to a peripheral site.Practically,it is
measured from the R wave on the ECG to the appearance
of the pulse wave at the finger. Pulse transit time is
inversely proportional to blood pressure,and so the drop
in blood pressure with inspiration determines rises in pulse
transit time.Pneumotachography is the standard method
to evaluate the airflow volume. Oxymetry by infrared
wavelength absorption is necessary to calculate the ratio
between oxyhemoglobin and reduced hemoglobin.The
sensors are placed on the finger,or on the ear or nose.
The clinical symptoms of the upper airway resistance
syndrome overlap widely those of the sleep apnea syn-
drome.
53 Patients affected are nonobese men or women,
with a complaint of excessive daytime sleepiness, snor-
ing (especially in men), with frequent fatigue upon
awakening. Clinical examination often reports a trian-
gular face,a small chin,an arched palate,a class II mal-




1. Gélineau J. De la narcolepsie. Gaz Hôp Paris. 1880;55:626-628 and 635-637.
2. Billiard M. Hypersomnias. In: Billiard M, ed. Sleep: Physiology, Investigations
and Medicine. New York, NY: Kluwer Academic/Plenum Publishers; 2003:333-
336.
3. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Ann
Rev Med. 1976;27:465-484.
4. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of
sleepiness. Psychophysiology. 1973;10:431-436.
5. Johns MW. A new method for measuring daytime sleepiness: the
Epworth Sleepiness Scale. Sleep. 1991;14:540-545.
6. Rechtschaffen A, Kales A, eds. A Manual of Standardized Terminology,
Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles,
Calif: Brain Information Service/Brain Research Institute; 1968.
7. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan
S. Guidelines for the Multiple Sleep Latency test (MSLT): a standard mea-
sure of sleepiness. Sleep. 1986;9:519-524.
8. American Academy of Sleep Medicine. International Classification of Sleep
Disorders, 2nd Edition: Diagnostic and Coding Manual. Westchester, Ill: American
Academy of Sleep Medicine; 2005.
9. Besset A. Assessing sleepiness. In: Billiard M, ed. Sleep: Physiology, Investigations
and Medicine. New York, NY: Kluwer Academic/Plenum Publishers; 2003:169-184.
10. Billiard M, Dauvilliers Y. Narcolepsy. In: Billiard M, ed. Sleep: Physiology,
Investigations and Medicine. New York, NY: Kluwer Academic/Plenum
Publishers; 2003:403-406.
11. Mignot E, Lin L, Rogers W, et al. Complex HLA-DR and -DQ interactions
confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet.
2000;68:686-699.
12. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid
hypocretin measurement in the diagnosis of narcolepsy and other hyper-
somnias. Arch Neurol. 2002;59:1553-1562.
13. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset
narcolepsy and a generalized absence of hypocretin peptides in human nar-
coleptic brains. Nat Med. 2000;6:991-997.
14. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocre-
tin neurons in human narcolepsy. Neuron. 2000;27:469-474.
occlusion,and a retroposition of the mandible.The diag-
nosis is ascertained during polysomnography associated
with esophageal pressure monitoring,by the presence of
repetitive increase in esophageal pressure that leads to
transient arousals without any changes in respiratory dis-
turbance index (index of apnea/hypopnea <5 per hour)
and in oxygen saturation.
Differential diagnosis with idiopathic hypersomnia
requires the recording of esophageal pressure.Here also,
the recording of esophageal pressure will show the grad-
ual increase in respiratory effort preceding the
microarousal.
Sleep is entirely disorganized, especially in apnea syn-
dromes.Microarousals due to respiratory efforts may add
up to hundreds of episodes during the night.Non-REM
sleep is highly fragmented and some patients do not
reach SWS.REM sleep is also fragmented.The patient is
sleep-deprived and daytime sleepiness may become
extreme.The apneic index,ie,the number of apneas per
hour of sleep,has long been used to quantify the breath-
ing disorder.
Treatment of apneic patients has been transformed by
the use of continuous positive airway pressure (CPAP)
of 5 to 15 cm H2O.
54The only disadvantage of such ther-
apy is the constraint to the patient and his or her partner.
Apneas are rapidly eradicated and the symptoms of the
illness disappear,especially daytime sleepiness.CPAP is
also efficient in the upper airway resistance syndrome,
though no other means have been tested extensively to
date.Mandibular advancement devices may be of value
in nonsevere cases of obstructive sleep apnea syndrome.
Postural alarm can be used in position-dependent apne-
ics.No specific medications,drugs (eg,ventilation stimu-
lants),or oxygen therapy have been shown to be effec-
tive on sleep apneas.In all cases,the patient should be
asked to lose weight.
Surgical treatments
55 are based on the identification of the
site of airway obstruction (nose,soft palate,and/or tongue).
The protocols include various forms of reconstruction
depending on the needs and the anatomy of the patient.
They range from tracheotomy, glossectomy (surgical
removal or laser evaporation of a portion of the tongue),
radiofrequency shrinkage of the obstructive tissues of the
upper airway (nose,palate,or tongue),or suspension tech-
niques with sutures of the tongue base,nasal reconstruc-
tion,uvulopalatopharyngoplasty,mandibular osteotomy
with genioglossus advancement,hyoid myotomy and sus-
pension,and maxillomandibular advancement.
Conclusion
Excessive daytime sleepiness is a frequent complaint in
industrialized societies,and has a significant impact on
work and family life.Physicians have several methods to
affirm the existence of daytime somnolence and diagnose
between the numerous causes of hypersomnia.They also
have access to large array of medications and therapeu-
tic strategies,which are constantly increasing in quantity
and quality. ❏
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Hipersomnia
La hipersomnia es la cantidad excesiva de sueño
durante el día o somnolencia excesivo y afecta al
4% a 6% de la población con un impacto en la vida
diaria del paciente. Hay herramientas metodológi-
cas para explorar el sueño y la vigilia (entrevista,
cuestionarios, diario de sueño, polisomnografía,
prueba de latencia múltiple del sueño, prueba de
mantención de la vigilia) y pruebas psicomotoras
(por ejemplo, la prueba de vigilancia psicomotora,
la prueba de resistencia al sueño de Oxford y la
prueba de Osler) que ayudan a distinguir las causas
de la hipersomnia. En este artículo las causas de
hipersomnia se detallan siguiendo la clasificación
convencional de síndromes hipersómnicos: narco-
lepsia, hipersomnia idiopática, hipersomnia recu-
rrente, síndrome de sueño insuficiente, somnolen-
cia por medicación o toxinas, hipersomnia asociada
con trastornos psiquiátricos, hipersomnia asociada
con trastornos neurológicos, hipersomnia postrau-
mática, infección e hipersomnia (con especial énfa-
sis en las diferencias entre enfermedades bacteria-
nas y virales comparadas con enfermedades
parasitarias, como la enfermedad del sueño), hiper-
somnia asociada con enfermedades metabólicas o
endocrinas, trastornos del sueño relacionados con
la respiración, síndromes de apnea del sueño, y sín-
drome de movimientos periódicos de extremidades
durante el sueño. 
Les hypersomnies
L’hypersomnie est une plainte de somnolence
diurne excessive qui affecte entre 4 et 6 % de la
population générale et influe sur la vie quotidienne
du patient. Le diagnostic étiologique de l’hyper-
somnie bénéficie d’une panoplie de questionnaires
et de tests qui explorent la qualité de l’éveil et du
sommeil du patient (entretien dirigé, question-
naires, agenda de sommeil, polysomnographie, test
de latence multiple du sommeil, test de maintien
de l’éveil) et de tests psychomoteurs capables d’éta-
blir le retentissement de la somnolence excessive
sur les performances mentales et l’équilibre psy-
chique du patient (par exemple, test de vigilance
psychomotrice, test de résistance au sommeil
d’Oxford, test d’Osler, etc.). Les différentes catégo-
ries d’hypersomnie sont détaillées selon la classifi-
cation conventionnelle actuelle : narcolepsie, hyper-
somnie idiopathique, hypersomnie récurrente,
syndrome d’insuffisance de sommeil, somnolence
liée aux médicaments et aux toxiques, hypersomnie
associée à des troubles psychiatriques, hypersomnie
associée à des troubles neurologiques, hypersom-
nie posttraumatique, hypersomnie liée à un syn-
drome infectieux (en insistant sur les différences
entre les infections virales et bactériennes, par rap-
port aux infections parasitaires telles que la mala-
die du sommeil), hypersomnie associée à des mala-
dies métaboliques ou endocriniennes, hypersomnie
associée aux mouvements périodiques des membres
et au syndrome des jambes sans repos, et hyper-
somnie liée aux syndromes d’apnées et d’hypo-
pnées au cours du sommeil.
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